Catalyst Wire Dossier Catalyst Wire Dossier

TIGLUTIK

RILUZOLE · EDW PHARMA, INC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TIGLUTIK, covering 2018-09-05 to 2025-09-11. Get the full timeline:

Most recent: FDA Approved: TIGLUTIK — Supplemental Application (EDW PHARMA, INC)

See pricing